Navigation Links
Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
Date:9/18/2009

GUATEMALA CITY, Sept. 18 /PRNewswire-FirstCall/ -- Cancer patients in Guatemala and across Central America now have access to advanced radiotherapy treatments, including intensity-modulated radiotherapy (IMRT) with RapidArc(R) technology. Hope International Centro de Radioterapia has become the first treatment center in Latin America to install the fast new treatment capability from Varian Medical Systems (NYSE: VAR).

With RapidArc, Hope International Centro de Radioterapia, a new privately-funded clinic, can provide more advanced care to a greater number of patients than would be possible with conventional technology. It is equipped with state-of-the-art technology for delivering the full spectrum of image-guided cancer treatments.

"We are able to offer IMRT, which targets cancer cells while minimizing damage to surrounding tissues and organs," says Luis A. Linares, MD, Medical Director. "With RapidArc, we have the potential to further enhance our precision by completing many of these treatments more quickly, which can reduce the extent of patient motion during treatment. All treatments will be delivered using a high resolution multileaf collimator to shape the treatment beam so that it matches the shape and size of the tumor from every angle."

The new treatment technology was unveiled on September 10, 2009, at an inauguration attended by many local dignitaries, including Alvaro Arzu, mayor of Guatemala City; cabinet-level government officials; medical specialists from across the region; and prominent leaders from the private sector.

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided IMRT two to eight times faster than is possible with conventional IMRT.

"This is an important facility for this part of Central America," said James Miles, Varian's director of operations for Latin American and the Caribbean. "We commend Dr. Linares and his team for taking the initiative to provide state-of-the-art cancer care for the people of Guatemala and surrounding region."

Photo available. (Left to right: Dr. Luis A. Linares and Alvaro Arzu, mayor of Guatemala City, with the RapidArc-enabled linear accelerator during the unveiling ceremony on September 10, 2009).

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com.

    FOR INFORMATION CONTACT:
    Meryl Ginsberg, Varian Medical Systems
    650-424-6444 or meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Houston Heart Surgeon Elected Vice President of Guatemala
2. Guatemalas Fundacion Ayudame a Vivir Fundraising Campaign Raises More Than $2.6 Million
3. Prosecutors Dismal Record Showing Improvement in Guatemala
4. Guatemalas Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation
5. Hard to Treat Diseases (HTDS) enters Guatemala market
6. Operation Walk Pittsburgh Performs Over 63 Free Surgeries in Guatemala
7. New treatment effective in counteracting cocaine-induced symptoms
8. New treatment boosts muscle function in myasthenia gravis
9. Broad-based group of physicians calls for improvement in stroke treatment
10. Cranberry Could Juice Up Ovarian Cancer Treatment
11. Non-medicinal treatment touted for pre-schoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Neil H. Greco ... planning assistance to communities throughout the region, is launching a charity drive to raise ... is by far the deadliest killer in America, and is responsible for 1 in ...
(Date:1/17/2017)... Los Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... today announced the results of a double blind clinical study for its dental gel ... to a leading national brand of toothpaste containing triclosan. The study was conducted at ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... from two offices in Tyler, has announced the latest beneficiary of their thriving ... Network, a nonprofit organization dedicated to fulfilling the dreams of terminally ill patients. ...
(Date:1/17/2017)... ... ... Today, FloSports , a global leader in live digital sports and original ... long-term extension of their media partnership. The partnership, which began in 2013, will now ... events exclusively on FloWrestling.com as well as usage of the FloArena meet management software ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
(Date:1/18/2017)... Jan. 18, 2017  Tarix Orphan LLC today announced ... a Rare Pediatric Disease (RPD) designation for the company,s ... Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. There ... is limited to supportive care. "The RPD ... Designation previously granted by the FDA in this indication," ...
(Date:1/18/2017)...  Robust competition in the private marketplace is resulting in ... to a new study by the Berkeley ... to examine the share of prescription medicine spending retained ... health plans and other stakeholders in the supply chain. ... show what happens when the list price of a ...
Breaking Medicine Technology: